IDEXX Laboratories (IDXX) Revenue — Quarter Ended Mar 31, 2024
Revenue for the quarter rose compared to both the prior quarter and the same period last year. The increase was driven by ongoing demand in the company's core markets.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue for the quarter rose compared to both the prior quarter and the same period last year. The increase was driven by ongoing demand in the company's core markets.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$964.1M
Revenue reported for this quarter.
Quarter-over-quarter
+6.9%
Change from the immediately preceding quarter.
Year-over-year
+7.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $943.6M | +9.7% |
| Sep 30, 2023 | $915.5M | +8.8% |
| Dec 31, 2023 | $901.6M | +8.8% |
| Mar 31, 2024 | $964.1M | +7.1% |
Revenue performance
Reported revenue was higher than the immediately preceding quarter, continuing an upward trend. The year-over-year comparison also showed an increase, though the pace of growth was slower than in the prior quarter's year-over-year comparison.
Quarterly comparison
Compared to the prior quarter, revenue increased. When measured against the same quarter one year earlier, revenue was also higher, but the magnitude of that annual increase was smaller than the annual increase seen in the immediately preceding quarter.
What to watch
Monitor whether the year-over-year growth rate continues to moderate in future quarters.